According to the data released by the government, the vaccine performed three to seven times better than other candidates, including those developed using mRNA technology....
They “intend to produce over 300 million doses in India per year”, said the Russian RDIF (Russian Direct Investment Fund). Serum Insurance of India (SII),...
On the subject of Sputnik V manufacturing, Serum Insitute has sought the DCGI’s permission for test analysis and examination. In case, it receives a go-ahead,...
Russia Scientists who developed the vaccine in an interaction with the media said that it produces enough antibodies to protect the person from the corona...